10-Deacetylbaccatin III

CAS No. 32981-86-5

10-Deacetylbaccatin III ( NSC 251677 )

Catalog No. M14090 CAS No. 32981-86-5

10-Deacetylbaccatin-III is an intermediate for taxol analog preparations.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 51 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    10-Deacetylbaccatin III
  • Note
    Research use only, not for human use.
  • Brief Description
    10-Deacetylbaccatin-III is an intermediate for taxol analog preparations.
  • Description
    10-Deacetylbaccatin-III is an intermediate for taxol analog preparations.
  • Synonyms
    NSC 251677
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    32981-86-5
  • Formula Weight
    544.59
  • Molecular Formula
    C29H36O10
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 109 mg/mL (200.15 mM)
  • SMILES
    O=C(O[C@@H]([C@@]1([H])[C@@]2(C)[C@@H](O)C[C@@]3([H])OC[C@]31OC(C)=O)[C@]4(O)C[C@H](O)C(C)=C(C4(C)C)[C@@H](O)C2=O)C5=CC=CC=C5
  • Chemical Name
    (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-4,6,9,11-tetrahydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang JF, et al. Cell Biol Int Rep (2010). 2010; 18(1):e00009.
molnova catalog
related products
  • (RS)-MCPG

    (RS)-MCPG is a non-selective group I/II metabotropic glutamate receptor antagonist.

  • BI-6C9

    BI-6C9 is an inhibitor of tBid (Kd = 20 μM).BI-6c9 prevented MOMP and mitochondrial fission and protected the cells from cell death.

  • Ingenol

    Ingenol mebutate is an effective treatment for actinic keratosis. 2. Formulating novel derivatives from Ingenol esters may be an innovative approach to develop new lead compounds to reactivate latent HIV.